GlassScriptPhysician profile
Anthony L Parks
NPI 1740375898
$1,298.08
in general payments reported to CMS, 2019-2025
22 companies · $148 in 2025
The $148 reported for 2025 was less than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
See the full distribution for Sports Medicine (Orthopaedic Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $198 · 2020: $32.35 · 2021: $248 · 2022: $160 · 2023: $366 · 2024: $146 · 2025: $148.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $660.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $660.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $289.82 | 2022-2023 | Seglentis |
| Smith+Nephew, INC. | $220.86 | 2023-2024 | Bone Anchors With Arthroscopic Delivery System |
| Zimmer Biomet Holdings, INC. | $148.15 | 2025 | Persona |
| Stryker Corporation | $104.47 | 2021-2024 | Inspace |
| Heron Therapeutics, INC. | $68.33 | 2021-2022 | |
| Medtronic, INC. | $63.52 | 2021-2022 | |
| Terumo Bct, INC. | $58.46 | 2019 | |
| Depuy Synthes Sales INC. | $48.43 | 2019-2021 | |
| Ethicon US, LLC | $35.90 | 2019-2021 | |
| Kerecis Limited | $30.77 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Bone Support INC. | $26.43 | 2024 | Ceramentbone Void Filler, Cerament G |
| Pfizer INC. | $26.20 | 2021 | |
| Abbott Laboratories | $25.92 | 2019 | |
| Daiichi Sankyo INC. | $25.65 | 2019-2020 | |
| Bioventus LLC | $20.25 | 2020 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intellijoint Surgical INC. | $20.01 | 2021 | |
| Ermi LLC | $17.55 | 2019 | |
| Trevena, INC. | $14.71 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $14.38 | 2022 | |
| Horizon Therapeutics Plc | $14.21 | 2019 | |
| Ferring Pharmaceuticals INC. | $13.20 | 2019 | |
| Mallinckrodt Enterprises LLC | $10.86 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Parks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.